Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H14N2O2 |
| Molecular Weight | 266.2946 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C(O)=O)C1=CC=C(C=C1)C2=CN3C=CC=CC3=N2
InChI
InChIKey=OJGQFYYLKNCIJD-UHFFFAOYSA-N
InChI=1S/C16H14N2O2/c1-11(16(19)20)12-5-7-13(8-6-12)14-10-18-9-3-2-4-15(18)17-14/h2-11H,1H3,(H,19,20)
| Molecular Formula | C16H14N2O2 |
| Molecular Weight | 266.2946 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Miroprofen, an imidazopyridine derivative, possesses anti-inflammatory properties. It was shown that this compound could be effective in suppressing pain responses and acute inflammation accompanied by increased vascular permeability. Analgesic effect of this compound was studied in post-extraction pain. However, information about the current study of this agent is not available.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Analgesic effects of miroprofen in post-extraction pain]. | 1983-05 |
|
| [Double blind controlled study of miroprofen in acute upper respiratory tract infections--comparison with ibuprofen]. | 1982-05 |
|
| Anti-inflammatory activity of an imidazopyridine derivative (miroprofen). | 1981 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:20:19 GMT 2025
by
admin
on
Mon Mar 31 18:20:19 GMT 2025
|
| Record UNII |
S00I5XG484
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C017978
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106551
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
68752
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
76249
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
S00I5XG484
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
Miroprofen
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
C90910
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
100000080647
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
SUB08994MIG
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
DTXSID30866515
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
55843-86-2
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
4938
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |